CD34 and acute myeloid leukemia: Furthermore, LINC01257 expression was absent in healthy progenitor CD34+ stem cells, MSCs and other subtypes of leukemia, highlighting the specificity of LINC01257 for AML and the value of its targeting as a precision medicine approach for this disease.